whole-genome microarray analysis Search Results


90
LabCorp whole-genome cnv microarray analysis
An overview of the overall positive genetic testing subcohort (n=43) examined <xref ref-type= a " width="250" height="auto" />
Whole Genome Cnv Microarray Analysis, supplied by LabCorp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/pmc04968978-96-1-9?v=LabCorp
Average 90 stars, based on 1 article reviews
whole-genome cnv microarray analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Phalanx Biotech whole genome microarray analysis
HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin <t>microarray</t> analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.
Whole Genome Microarray Analysis, supplied by Phalanx Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/pmc06335691-169-13-20?v=Phalanx+Biotech
Average 90 stars, based on 1 article reviews
whole genome microarray analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
WholeGenome LLC microarray expression analysis
HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin <t>microarray</t> analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.
Microarray Expression Analysis, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/10__1128_slash_iai__01495___08-168-17-17?v=WholeGenome+LLC
Average 90 stars, based on 1 article reviews
microarray expression analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
WholeGenome LLC microarray analysis system
HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin <t>microarray</t> analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.
Microarray Analysis System, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/10__1128_slash_jvi__01158___06-30-22-22?v=WholeGenome+LLC
Average 90 stars, based on 1 article reviews
microarray analysis system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Markstein Sichtec Medical whole-genome microarray analysis
HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin <t>microarray</t> analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.
Whole Genome Microarray Analysis, supplied by Markstein Sichtec Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/pm38869221-80-27-48?v=Markstein+Sichtec+Medical
Average 90 stars, based on 1 article reviews
whole-genome microarray analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Micromatrices whole genome microarray analysis (transcriptional profiling)
HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin <t>microarray</t> analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.
Whole Genome Microarray Analysis (Transcriptional Profiling), supplied by Micromatrices, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole-genome+microarray+analysis/pm40504036-74-27-33?v=Micromatrices
Average 90 stars, based on 1 article reviews
whole genome microarray analysis (transcriptional profiling) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


An overview of the overall positive genetic testing subcohort (n=43) examined <xref ref-type= a " width="100%" height="100%">

Journal: The Application of Clinical Genetics

Article Title: Examining genotypic variation in autism spectrum disorder and its relationship to parental age and phenotype

doi: 10.2147/TACG.S112712

Figure Lengend Snippet: An overview of the overall positive genetic testing subcohort (n=43) examined a

Article Snippet: The blood whole-genome CNV microarray analysis was conducted by LabCorp either using 1.8 million or 2.695 million genotyping targets.

Techniques: Translocation Assay, Variant Assay, Microarray

HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin microarray analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.

Journal: BMC Cancer

Article Title: Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells

doi: 10.1186/s12885-018-5129-4

Figure Lengend Snippet: HDAC inhibitor treatment significantly impacts SW13 cell lectin binding and sulfation status. Total protein was isolated from SW13 control cells and SW13 cells that had been treated with 1 nM FK228 for 24 h ( n = 4 per group). a FK228 treated SW13 cells have significantly higher levels of GAG-chain sulfation compared to SW13 control cells. b Lysates were subjected to lectin microarray analysis. Histograms of the fluorescence intensities lectins which were differentially bound between SW13 control cells and FK228 treated cells are shown. Data are presented as means ± SEM. c Lectin blots were performed to confirm lectin array results of select lectins (ConA, LPA, GS-I, Lotus, AIA, MPA, and ECA) that were differentially bound. DBA and UAE-1 were stained as negative controls. *Denotes statistical difference compared to control SW13- cells, p < 0.05.

Article Snippet: Following quality control analysis (260/230 > 1.5, 260/280 > 1.8, RIN > 6), whole genome microarray analysis was performed by PhalanxBiotech using their OneArray platform.

Techniques: Binding Assay, Isolation, Control, Microarray, Fluorescence, Staining